Terms: = Bone cancer AND HOXD13, SPD, 3239, P35453, HOX4I
39 results:
1. Iron chelation improves ineffective erythropoiesis and iron overload in myelodysplastic syndrome mice.
An W; Feola M; Levy M; Aluri S; Ruiz-Martinez M; Sridharan A; Fibach E; Zhu X; Verma A; Ginzburg Y
Elife; 2023 Dec; 12():. PubMed ID: 38153418
[TBL] [Abstract] [Full Text] [Related]
2. Patterns of progression on first line osimertinib in patients with EGFR mutation-positive advanced non-small cell lung cancer (NSCLC): A Swiss cohort study.
Schuler A; Huser J; Schmid S; Schär S; Scherz A; Gautschi O; Mauti L; von Briel T; Waibel C; Wannesson L; Pankovics J; Mark MT; Rothschild SI; Addeo A; Janthur WD; Siano M; Boos L; Britschgi C; Früh M
Lung Cancer; 2024 Jan; 187():107427. PubMed ID: 38043395
[TBL] [Abstract] [Full Text] [Related]
3. The bone marrow stroma in human myelodysplastic syndrome reveals alterations that regulate disease progression.
Kfoury YS; Ji F; Jain E; Mazzola M; Schiroli G; Papazian A; Mercier F; Sykes DB; Kiem A; Randolph M; Calvi LM; Abdel-Wahab O; Sadreyev RI; Scadden DT
Blood Adv; 2023 Nov; 7(21):6608-6623. PubMed ID: 37450380
[TBL] [Abstract] [Full Text] [Related]
4. The Programmed Death-1 Pathway Counter-Regulates Inflammation-Induced Osteoclast Activity in Clinical and Experimental Settings.
Greisen SR; Kragstrup TW; Thomsen JS; Hørslev-Pedersen K; Hetland ML; Stengaard-Pedersen K; Østergaard M; Ørnbjerg L; Junker P; Sharpe AH; Freeman GJ; Hvid M; Moestrup SK; Hauge EM; Deleuran B
Front Immunol; 2022; 13():773946. PubMed ID: 35356000
[TBL] [Abstract] [Full Text] [Related]
5. hoxd13 suppresses prostate cancer metastasis and BMP4-induced epithelial-mesenchymal transition by inhibiting SMAD1.
Xu F; Shangguan X; Pan J; Yue Z; Shen K; Ji Y; Zhang W; Zhu Y; Sha J; Wang Y; Fan L; Dong B; Wang Q; Xue W
Int J Cancer; 2021 Jun; 148(12):3060-3070. PubMed ID: 33521930
[TBL] [Abstract] [Full Text] [Related]
6. Comparative analysis of the levels of soluble forms of receptor and ligand of the immunity control point PD-1/PD-L1 in the blood serum of patients with typical bone osteosarcoma and chondrosarcoma.
Kushlinskii NE; Alferov AA; Boulytcheva IV; Timofeev YS; Korotkova EA; Khvan OT; Kuzmin YB; Kuznetsov IN; Bondarev AV; Shchupak MY; Sokolov NY; Efimova MM; Gershtein ES; Sushentsov EA; Aliev MD; Musaev ER
Klin Lab Diagn; 2020 Dec; 65(11):669-675. PubMed ID: 33301655
[TBL] [Abstract] [Full Text] [Related]
7. Key Immune Checkpoint PD-1/PD-L1 Signaling Pathway Components in the Blood Serum from Patients with bone Tumors.
Kushlinskii NE; Alferov AA; Timofeev YS; Gershtein ES; Bulycheva IV; Bondarev AV; Shchupak MY; Sokolov NY; Polikarpova SB; Efimova MM; Dzampaev AA; Sushentsov EA; Aliev MD; Musaev ER
Bull Exp Biol Med; 2020 Nov; 170(1):64-68. PubMed ID: 33231796
[TBL] [Abstract] [Full Text] [Related]
8. Increased FGF-23 levels are linked to ineffective erythropoiesis and impaired bone mineralization in myelodysplastic syndromes.
Weidner H; Baschant U; Lademann F; Ledesma Colunga MG; Balaian E; Hofbauer C; Misof BM; Roschger P; Blouin S; Richards WG; Platzbecker U; Hofbauer LC; Rauner M
JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32759495
[TBL] [Abstract] [Full Text] [Related]
9. SETD2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in MDS.
Chen BY; Song J; Hu CL; Chen SB; Zhang Q; Xu CH; Wu JC; Hou D; Sun M; Zhang YL; Liu N; Yu PC; Liu P; Zong LJ; Zhang JY; Dai RF; Lan F; Huang QH; Zhang SJ; Nimer SD; Chen Z; Chen SJ; Sun XJ; Wang L
Blood; 2020 Jun; 135(25):2271-2285. PubMed ID: 32202636
[TBL] [Abstract] [Full Text] [Related]
10. Thymic precursor cells generate acute myeloid leukemia in NUP98-PHF23/NUP98-hoxd13 double transgenic mice.
Kundu S; Park ES; Chung YJ; Walker RL; Zhu YJ; Negi V; Meltzer PS; Aplan PD
Sci Rep; 2019 Nov; 9(1):17213. PubMed ID: 31748606
[TBL] [Abstract] [Full Text] [Related]
11. Comparison of bone scintigraphy and Ga-68 prostate-specific membrane antigen positron emission tomography/computed tomography in the detection of bone metastases of prostate carcinoma.
Soydal C; Nak D; Araz M; Akkus P; Urun Y; Ozkan E; Kucuk NO; Kir MK
Nucl Med Commun; 2019 Dec; 40(12):1243-1249. PubMed ID: 31688499
[TBL] [Abstract] [Full Text] [Related]
12. Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome.
Chung YJ; Khawaja G; Wolcott KM; Aplan PD
J Vis Exp; 2018 Oct; (140):. PubMed ID: 30346380
[TBL] [Abstract] [Full Text] [Related]
13. Impact of serum soluble programed death ligand 1 on end of treatment metabolic response of diffuse large B cell lymphoma patients.
El-Ghammaz AMS; Gadallah HA; Kamal G; Maher MM; Mohamad MA
Clin Exp Med; 2018 Nov; 18(4):505-512. PubMed ID: 29876769
[TBL] [Abstract] [Full Text] [Related]
14. Epigenetically Aberrant Stroma in MDS Propagates Disease via Wnt/β-Catenin Activation.
Bhagat TD; Chen S; Bartenstein M; Barlowe AT; Von Ahrens D; Choudhary GS; Tivnan P; Amin E; Marcondes AM; Sanders MA; Hoogenboezem RM; Kambhampati S; Ramachandra N; Mantzaris I; Sukrithan V; Laurence R; Lopez R; Bhagat P; Giricz O; Sohal D; Wickrema A; Yeung C; Gritsman K; Aplan P; Hochedlinger K; Yu Y; Pradhan K; Zhang J; Greally JM; Mukherjee S; Pellagatti A; Boultwood J; Will B; Steidl U; Raaijmakers MHGP; Deeg HJ; Kharas MG; Verma A
Cancer Res; 2017 Sep; 77(18):4846-4857. PubMed ID: 28684528
[TBL] [Abstract] [Full Text] [Related]
15. Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy.
Nagato T; Ohkuri T; Ohara K; Hirata Y; Kishibe K; Komabayashi Y; Ueda S; Takahara M; Kumai T; Ishibashi K; Kosaka A; Aoki N; Oikawa K; Uno Y; Akiyama N; Sado M; Takei H; Celis E; Harabuchi Y; Kobayashi H
Cancer Immunol Immunother; 2017 Jul; 66(7):877-890. PubMed ID: 28349165
[TBL] [Abstract] [Full Text] [Related]
16. The posterior HOXD locus: Its contribution to phenotype and malignancy of Ewing sarcoma.
von Heyking K; Roth L; Ertl M; Schmidt O; Calzada-Wack J; Neff F; Lawlor ER; Burdach S; Richter GH
Oncotarget; 2016 Jul; 7(27):41767-41780. PubMed ID: 27363011
[TBL] [Abstract] [Full Text] [Related]
17. Image intensive soft tissue sarcoma surveillance uncovers pathology earlier than patient complaints but with frequent initially indeterminate lesions.
Richardson K; Potter M; Damron TA
J Surg Oncol; 2016 Jun; 113(7):818-22. PubMed ID: 27060189
[TBL] [Abstract] [Full Text] [Related]
18. PUMA promotes apoptosis of hematopoietic progenitors driving leukemic progression in a mouse model of myelodysplasia.
Guirguis AA; Slape CI; Failla LM; Saw J; Tremblay CS; Powell DR; Rossello F; Wei A; Strasser A; Curtis DJ
Cell Death Differ; 2016 Jun; 23(6):1049-59. PubMed ID: 26742432
[TBL] [Abstract] [Full Text] [Related]
19. Overexpression of HOX genes is prevalent in Ewing sarcoma and is associated with altered epigenetic regulation of developmental transcription programs.
Svoboda LK; Harris A; Bailey NJ; Schwentner R; Tomazou E; von Levetzow C; Magnuson B; Ljungman M; Kovar H; Lawlor ER
Epigenetics; 2014 Dec; 9(12):1613-25. PubMed ID: 25625846
[TBL] [Abstract] [Full Text] [Related]
20. Characterizing the impact of lymph node metastases on the survival outcome for metastatic renal cell carcinoma patients treated with targeted therapies.
Kroeger N; Pantuck AJ; Wells JC; Lawrence N; Broom R; Kim JJ; Srinivas S; Yim J; Bjarnason GA; Templeton A; Knox J; Bernstein E; Smoragiewicz M; Lee J; Rini BI; Vaishampayan UN; Wood LA; Beuselinck B; Donskov F; Choueiri TK; Heng DY
Eur Urol; 2015 Sep; 68(3):506-15. PubMed ID: 25524810
[TBL] [Abstract] [Full Text] [Related]
[Next]